Current Challenges and Emerging Treatments for the Management of Severe Hypertriglyceridemia

Learn best practices for the treatment and management of patients with severe hypertriglyceridemia, including those with familial chylomicronemia syndrome, and assess current data and trends of the emerging therapies for these conditions.

Share

Program Content

Activities

Severe Hypertriglyceridemia
Current Challenges and Emerging Treatments for the Management of Severe Hypertriglyceridemia
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: January 28, 2024

Expires: January 29, 2025

Activities

FCS QOL
Familial Chylomicronemia Syndrome: Diagnosis and Impact on Quality of Life
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2023

Severe HTG
Severe Hypertriglyceridemia: Causes, Current Treatments, and Emerging Therapies
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 01, 2024

Activities

Severe Hypertriglyceridemia
Current Challenges and Emerging Treatments for the Management of Severe Hypertriglyceridemia
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: January 29, 2024

Faculty

cover img faculity

Michael Miller, MD, FACC, FAHA

Cardiologist & Professor of Medicine
Hospital of the University of Pennsylvania
Chief of Medicine
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.